Engineered-affibody conjugates contribute to the specific targeting and cellular retention of polyplexes in Erbb3 overexpressed lung cancer cells.

Chen S, Nguyen A, Müller JT, Molbay M, Mehta A, Sheshachala S, Baskaya K, Adams N, Pinto Carneiro S, Merkel OM

DOI: 10.1016/j.ejps.2025.107090
Published: 2025 Jun 1
Container: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.ejps.2025.107090,
  title = {Engineered-affibody conjugates contribute to the specific targeting and cellular retention of polyplexes in Erbb3 overexpressed lung cancer cells.},
  author = {Chen S and Nguyen A and Müller JT and Molbay M and Mehta A and Sheshachala S and Baskaya K and Adams N and Pinto Carneiro S and Merkel OM},
  year = {2025},
  journal = {European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences},
  doi = {10.1016/j.ejps.2025.107090},
  url = {https://doi.org/10.1016/j.ejps.2025.107090}
}

RIS

TY  - JOUR
TI  - Engineered-affibody conjugates contribute to the specific targeting and cellular retention of polyplexes in Erbb3 overexpressed lung cancer cells.
AU  - Chen S
AU  - Nguyen A
AU  - Müller JT
AU  - Molbay M
AU  - Mehta A
AU  - Sheshachala S
AU  - Baskaya K
AU  - Adams N
AU  - Pinto Carneiro S
AU  - Merkel OM
PY  - 2025
JO  - European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
DO  - 10.1016/j.ejps.2025.107090
UR  - https://doi.org/10.1016/j.ejps.2025.107090
ER  -

APA

S, C., A, N., JT, M., M, M., A, M., S, S., K, B., N, A., S, P. C., & OM, M. (2025). Engineered-affibody conjugates contribute to the specific targeting and cellular retention of polyplexes in Erbb3 overexpressed lung cancer cells.. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. https://doi.org/10.1016/j.ejps.2025.107090

Source records

pubmed · retrieved 2026-09-25T23:44:26.765Z
europe-pmc · retrieved 2026-09-25T23:44:26.777Z